Dan Mendelson, MPP, founder, Avalere Health, outlines the impact recent healthcare policy changes have on pharmacists and providers.
Dan Mendelson, MPP, founder, Avalere Health, outlines what recent healthcare policy changes Avalere Health is paying the most attention to.
TranscriptWhat recent healthcare policy changes has Avalere Health been paying the most attention to?
This is a really vibrant and rapidly changing environment, and I think it’s important for pharmacists to understand that they are really living in a context of a lot of change. A lot of the change is focused around the health plan world. So, health plans today are increasingly being asked to take risk, to improve quality for patients, and really to start to integrate some of the pharmacy offerings into the medical aspects of the offerings. So, the plan environment is changing rapidly, quality measures are really driving a lot of the activity in plans, and that’s kind of the first major piece that’s of relevance.
Second, I’d say that in the provider world, a lot of those incentives that the plans are under are now trickling down into the provider space. I mean, providers know that they are not going to be the one to immunize the patient, they’re not going to be the ones to hand them their medication. So, the plans know that, and the providers ultimately need to be aligned into the kinds of incentives that exist in that context. So, that’s another aspect.
I’d say also that the individual markets are important for pharmacists. The reality is that the individual markets are small as a percentage of total markets but are driving a lot of the trends that we are seeing: high-deductible health plans, restrictive networks, and the like. So, those are some of the things we’re most focused on, and I think kind of speak to the importance of understanding the change environment.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More